These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8917636)

  • 1. Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes.
    DeBruyne LA; Chang AE; Cameron MJ; Yang Z; Gordon D; Nabel EG; Nabel GJ; Bishop DK
    Cancer Immunol Immunother; 1996 Sep; 43(1):49-58. PubMed ID: 8917636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J; Birck A; Straten PT
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
    Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
    Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
    Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
    Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
    Schøller J; thor Straten P; Birck A; Siim E; Dahlström K; Drzewiecki KT; Zeuthen J
    Cancer Immunol Immunother; 1994 Oct; 39(4):239-48. PubMed ID: 7954526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
    J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
    Nishimura MI; Kawakami Y; Charmley P; O'Neil B; Shilyansky J; Yannelli JR; Rosenberg SA; Hood L
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):85-94. PubMed ID: 7804531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma.
    Ebato M; Nitta T; Yagita H; Sato K; Okumura K
    Immunol Lett; 1993 Dec; 39(1):53-64. PubMed ID: 8144191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
    Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
    Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor V alpha and V beta gene usage by tumour-infiltrating lymphocytes in oral squamous cell carcinoma.
    Mouri T; Nakamura S; Ohyama Y; Matsuzaki G; Shinohara M; Kishihara K; Hiroki A; Oka M; Shirasuna K; Nomoto K
    Cancer Immunol Immunother; 1996 Sep; 43(1):10-8. PubMed ID: 8917630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.
    Fisk B; Flytzanis CN; Pollack MS; Wharton JT; Ioannides CG
    Scand J Immunol; 1994 Dec; 40(6):591-600. PubMed ID: 7848491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective accumulation of T cells according to T-cell receptor V beta gene usage in skin cancer.
    Ohmen JD; Moy RL; Zovich D; Lieberman A; Wyzykowski RJ; Sullivan L; Modlin RL; Uyemura K
    J Invest Dermatol; 1994 Dec; 103(6):751-7. PubMed ID: 7798611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
    Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes.
    Nabel GJ; Gordon D; Bishop DK; Nickoloff BJ; Yang ZY; Aruga A; Cameron MJ; Nabel EG; Chang AE
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15388-93. PubMed ID: 8986821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.